McLachlan Andrew J, Aslani Parisa
Sydney Pharmacy School, Faculty of Medicine and Health, The University of Sydney.
Aust Prescr. 2020 Feb;43(1):24-26. doi: 10.18773/austprescr.2020.007. Epub 2020 Feb 3.
Australia’s National Medicines Policy was launched 20 years ago with the aim of improving health outcomes for all Australians. It was developed in partnership with healthcare professionals, consumers and the pharmaceutical industry The key parts of the Policy focus on timely access to high-quality and affordable medicines and their safe and judicious use. It also supports a viable and responsible pharmaceutical industry Since the Policy was first launched, Australia has seen significant changes in healthcare systems, medicines subsidies, health services remuneration, digital technologies and the pharmaceutical industry Medicines themselves have also changed, as have consumers’ expectations. To respond to these changes, the National Medicines Policy needs to be updated with a greater focus on implementing and measuring outcomes
澳大利亚的《国家药品政策》于20年前推出，旨在改善全体澳大利亚人的健康状况。该政策是与医疗保健专业人员、消费者和制药行业合作制定的。该政策的关键部分侧重于及时获得高质量且价格合理的药品，以及安全、合理地使用这些药品。它还支持一个可行且负责的制药行业。自该政策首次推出以来，澳大利亚的医疗保健系统、药品补贴、医疗服务薪酬、数字技术和制药行业都发生了重大变化。药品本身也发生了变化，消费者的期望同样如此。为应对这些变化，需要更新《国家药品政策》，更加注重成果的落实和衡量。
